Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousTissue DonorsGraft vs Host DiseaseHistocompatibility TestingTransplantation, AutologousWhole-Body IrradiationHistocompatibilityAnemia, AplasticHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemiaBone and BonesGraft SurvivalHematopoietic Stem CellsLiver TransplantationTransplantation ChimeraBone Marrow PurgingBone Marrow DiseasesBusulfanHLA AntigensGraft vs Host ReactionBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCyclophosphamideLeukocyte TransfusionTransplantation, IsogeneicHematopoiesisRecurrenceLiving DonorsHematologic NeoplasmsTissue and Organ ProcurementKidney TransplantationGraft RejectionTreatment OutcomeTime FactorsMice, Inbred C57BLBone Marrow NeoplasmsRadiation ChimeraBlood DonorsImmunosuppressionCombined Modality TherapyLeukemia, Myeloid, AcuteAcute DiseaseImmunosuppressive AgentsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesSurvival AnalysisHepatic Veno-Occlusive DiseaseRetrospective StudiesLeukemia, MyeloidColony-Forming Units AssayTransplantation ImmunologyBone RemodelingLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinHeart TransplantationChimeraMyelodysplastic SyndromesCord Blood Stem Cell TransplantationSevere Combined ImmunodeficiencySurvival RateCell DifferentiationDisease-Free SurvivalHematologic DiseasesLung TransplantationCyclosporineActuarial AnalysisPancytopeniaLymphocyte TransfusionSpleenBone DensityAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyLeukocyte CountFlow CytometryCarmustineOrgan TransplantationGranulocyte Colony-Stimulating FactorCells, CulturedFollow-Up StudiesMice, Inbred BALB CGraft vs Tumor EffectCytarabineCytomegalovirus InfectionsMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34Bone ResorptionMelphalanLymphomaGranulocytesEtoposideMice, KnockoutRegistriesImmunophenotyping